Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC in Fibromyalgia Pain Modulation
NCT05644054Recruiting
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jan 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dronabinol in fibromyalgia (FM), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Functional Connectivity at 2 hours and Blood Oxygenation Level at 2 hours. Started Jan 2023; status: recruiting.
02
Drugs
dronabinol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05644054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644054.